UPL Ltd. shares soared over 5% today after brokerage firm Investec upgraded its rating to ‘Buy’ from ‘Sell’ and raised its price target by 56% to ₹700 from ₹450. The revised target implies a 16% upside from current levels.
Brokerage and Market Reaction:
- Investec’s Rating: Upgraded to ‘Buy’
- Revised Target: ₹700 per share
- Potential Upside: 16% from current trading levels
Investec highlighted that UPL’s better-than-expected operational performance, coupled with an improving outlook and favorable valuations, has significantly contributed to the upgrade. The firm also raised its EBITDA estimates by 1-3% for FY25-FY27, citing a global recovery in demand and operational efficiency as key drivers.
Strong Q3 Financial Highlights:
- Net Profit: ₹828 crore compared to a net loss of ₹1,217 crore in the same quarter last year
- Revenue: ₹10,907 crore, a 10% YoY growth driven by a 9% volume increase and a 5% price hike
- Forex Impact: Issues, particularly in Brazil, partially offset gains
The company attributed its strong Q3 performance to the recovery in global demand, which allowed it to regain high contribution margins. Additionally, the completion of global destocking has further supported its recovery trajectory.
Debt Reduction Initiatives:
UPL has effectively reduced its net debt by $745 million during the quarter compared to last year. Although net debt remains higher by $363 million compared to March 2024, the company remains optimistic about reducing debt further through:
- Proceeds from its rights issue
- Sale of its stake in Advanta
- Operating cash flows
CEO Commentary:
Jai Shroff, Chairman and Group CEO, said, “We are witnessing a strong bounce back compared to last year, with business normalization and recovery of volumes and prices. This has significantly contributed to restoring our high contribution margins.”
With UPL expected to deliver on its EBITDA and free cash flow guidance, analysts anticipate sustained momentum for the agrochemicals giant in the upcoming quarters.